NCT00002112View on ClinicalTrials.gov

Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Candidiasis, OralHIV Infections
Interventions
DRUG

Nystatin

DRUG

Fluconazole

Trial Locations (5)

19129

Med College of Pennsylvania, Philadelphia

21205

Johns Hopkins School of Medicine, Baltimore

23666

Hampton Roads Med Specialists, Hampton

93726

California Med Research Group, Fresno

94143

UCSF Hosp, San Francisco

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00002112 - Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome | Biotech Hunter | Biotech Hunter